Another study demonstrated reduced levels of IgG and IgM antibodies against TF and MUC1 antigens in gastric cancer (GC) patients compared with healthy donors, though notably, the median age of the patients (65 years) differed significantly from that of the donors (51 years) [15]. This evidence concerns the gene CD40LG and gastric cancer.